“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
In the years just prior to onset of the COVID-19 pandemic in 2019-2020, there was a mysterious polio-like syndrome emerging among some children in the United States, as well as other countries such as India, called acute flaccid myelitis (AFM)—also sometimes referred to as acute flaccid paralysis (AFP). The U.S. Centers for Disease Control and […]
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
Pfizer and its German partner BioNTech on Monday announced two of their experimental coronavirus vaccines received Fast Track designation from the U.S. Food and Drug Administration, meaning the FDA may decide on an approval within six months. If a vaccine candidate gets the green light, the companies said they expect to make up to a […]
The American Cancer Society (ACS) updated its guidelines for human papilloma virus (HPV) vaccination on July 8, 2020 and now recommends that doctors and other healthcare providers routinely administer the two-dose HPV vaccination series to boys and girls between the ages of nine and 10.1 Currently, the federal Advisory Committee on Immunization Practices (ACIP) recommends […]
Story Highlights A new Lyme disease vaccine candidate approved by the FDA using the fast track process is currently in its second phase of clinical trials. In 1998, the FDA granted licensure for a Lyme disease vaccine called LYMErix. Following reports of severe adverse reactions to LYMErix, GlaxoSmithKline (formerly SmithKline Beecham) withdrew the vaccine from […]